[{"uuid": "51fbe1a2-90dc-3e07-a59a-71340868d2bb", "title": "Wolfe Research Initiates Coverage on 89bio With Outperform Rating, $15 Price Target", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/wolfe-research-initiates-coverage-89bio-122026392.html", "providerPublishTime": 1738671626, "type": "STORY"}, {"uuid": "90f8d091-3076-3d15-983c-d4981ff0a54c", "title": "Wall Street Analysts Think 89BIO (ETNB) Could Surge 219.06%: Read This Before Placing a Bet", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/wall-street-analysts-think-89bio-145507067.html", "providerPublishTime": 1738594507, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/T44Iwg7RbRrkaTIYz_liyQ--~B/aD00Njk7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2", "width": 900, "height": 469, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/0VAyjhJrJObsyjxSwVSkjQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "b73362b9-d781-3dbf-945c-fa47337354f0", "title": "89bio Closes $287.5 Million Public Offering", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/89bio-closes-287-5-million-161653697.html", "providerPublishTime": 1738599413, "type": "STORY", "relatedTickers": ["ETNB"]}, {"uuid": "159072db-04ab-37d5-8f45-d6768ba2023a", "title": "89bio Announces Closing of its Public Offering and Full Exercise of Underwriters\u2019 Option to Purchase Additional Shares", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/89bio-announces-closing-public-offering-130000215.html", "providerPublishTime": 1738587600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 181, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/h9Vq1_eqmZVOLrEX3CMxeQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB"]}, {"uuid": "34d83d28-9cd5-3a45-9ffc-912bd8610855", "title": "89bio Prices $250 Million Offering of Stock, Warrants", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/89bio-prices-250-million-offering-094744051.html", "providerPublishTime": 1738144064, "type": "STORY"}, {"uuid": "25cb2a87-319d-3c0c-9cbc-92b09817b8d2", "title": "Why 89bio Stock Lagged the Market Today", "publisher": "Motley Fool", "link": "https://finance.yahoo.com/m/25cb2a87-319d-3c0c-9cbc-92b09817b8d2/why-89bio-stock-lagged-the.html", "providerPublishTime": 1738101540, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/RLranwE4wNF7NzPtfVpyWA--~B/aD00NDgwO3c9NjcyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/733bb21f0f93ce558adcfdaac1bdd264", "width": 6720, "height": 4480, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/kKg9H72KRWZsDY06c5zFZA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/733bb21f0f93ce558adcfdaac1bdd264", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB", "^GSPC"]}, {"uuid": "02da0f88-df1a-3b85-923e-686723b99632", "title": "89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/89bio-inc-announces-pricing-250-033100401.html", "providerPublishTime": 1738121460, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 181, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/h9Vq1_eqmZVOLrEX3CMxeQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB"]}, {"uuid": "165bbe34-55f4-3506-8edc-dc9d511d3a8b", "title": "AKRO Stock Doubles in a Week as Lead Drug Meets Goal in MASH Study", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/akro-stock-doubles-week-lead-151500816.html", "providerPublishTime": 1738163700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rW4gwx51VaA5gxTyv4MLeg--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/004265dfd2737a0262868ee5a83c126c", "width": 620, "height": 413, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z8lneb0ND8JiUY2R3XiQ6g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/004265dfd2737a0262868ee5a83c126c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKRO", "NVO"]}, {"uuid": "ae95a77f-ec63-39a5-87d9-361439c5e5ca", "title": "89bio Launches $250 Million Securities Offering -- Shares Down After Hours", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/89bio-launches-250-million-securities-223705829.html", "providerPublishTime": 1738017425, "type": "STORY"}, {"uuid": "4a96ff8e-1abe-344d-a4d1-fbc200b7cd47", "title": "89bio, Inc. Announces Proposed Underwritten\u00a0Public Offering of Common Stock and Pre-Funded Warrants", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/89bio-inc-announces-proposed-underwritten-211200269.html", "providerPublishTime": 1738012320, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 181, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/h9Vq1_eqmZVOLrEX3CMxeQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB"]}, {"uuid": "2db75f61-4425-3fe6-a435-6255fe7b3335", "title": "Akero Therapeutics Stock Nearly Doubles \u2014 Pulling 89bio Higher \u2014 On Positive MASH Study", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/2db75f61-4425-3fe6-a435-6255fe7b3335/akero-therapeutics-stock.html", "providerPublishTime": 1738013051, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QZf4xlQ7AfcByP1Y9jVFDQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/a5117117c5db4cead98ead82d618526b", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ZVISK45D33HzZdXWuSWmmg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/a5117117c5db4cead98ead82d618526b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKRO", "ETNB"]}, {"uuid": "4cd5ca08-bae9-36d9-b1ca-42b5f974be28", "title": "Akero's Stock Skyrockets 112% After Game-Changing Liver Drug Data", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/akeros-stock-skyrockets-112-game-171334490.html", "providerPublishTime": 1737998014, "type": "STORY", "relatedTickers": ["AKRO"]}, {"uuid": "288d2041-51b8-369e-ad1c-722d433f0cdf", "title": "Top Premarket Gainers", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-premarket-gainers-124204597.html", "providerPublishTime": 1737981724, "type": "STORY", "relatedTickers": ["JG", "AKRO"]}, {"uuid": "3d15ef79-022b-33bc-bb62-80aebb61df71", "title": "89bio Provides Business Update and Outlook for 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/89bio-provides-business-outlook-2025-130000542.html", "providerPublishTime": 1736773200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 181, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/h9Vq1_eqmZVOLrEX3CMxeQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB"]}, {"uuid": "37003767-793b-3afd-9fb6-847bd3646f12", "title": "New Strong Sell Stocks for January 7th", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/strong-sell-stocks-january-7th-081700612.html", "providerPublishTime": 1736237820, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TnZya4zmXcZQTiM85rn8xg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Vz7YhmrSejxTxvuTvLY7xA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB", "ATUS", "ASH"]}, {"uuid": "d00f980c-0815-35a6-aca6-7c9cb3091f88", "title": "89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/89bio-announces-inducement-grants-under-210500686.html", "providerPublishTime": 1734642300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 181, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/h9Vq1_eqmZVOLrEX3CMxeQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB"]}, {"uuid": "ce5addba-48cf-353c-85fb-a23c18d73fdf", "title": "New Strong Sell Stocks for November 16th", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/strong-sell-stocks-november-16th-105900112.html", "providerPublishTime": 1734346740, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0LyNBdidj_xj8ehhpBX8YA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4d335bd14592d76b641324eb63233abe", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/sBxdNUfJQ9kQ_8SmRy1S2A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/4d335bd14592d76b641324eb63233abe", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HZO"]}, {"uuid": "e547fc47-e323-3e10-a5e6-92a54318b015", "title": "Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-89bio-inc-etnb-among-180208816.html", "providerPublishTime": 1733335328, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/vltckEnnUuES2V6oh1IJuw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/272578386575f8f9a3f5a3b25844931b", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/hVDIbOY2FT4b6DVondeGtA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/272578386575f8f9a3f5a3b25844931b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB"]}, {"uuid": "12c9af4c-09fd-32a5-a837-1b06bbbb98e1", "title": "89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/89bio-inc-announces-upsized-pricing-045800092.html", "providerPublishTime": 1731473880, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 181, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/h9Vq1_eqmZVOLrEX3CMxeQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB"]}, {"uuid": "919f0607-93f0-30c4-88f2-69aa7f78cbeb", "title": "89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting\u00ae 2024", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/89bio-presents-analyses-evaluating-pegozafermin-130500115.html", "providerPublishTime": 1731675900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 181, "height": 68, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/h9Vq1_eqmZVOLrEX3CMxeQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ETNB"]}]